On the recordMarch 19, 2013
I think it is quite challenging for the FDA and for many reasons to stay as current as possible on those things which are simply just emerging.
Source
congress.govEditor's note · Context
Smith discusses the FDA's struggle to keep up with emerging technologies.
Share & report
More from Madison Smith
Jun 12, 2024
I am glad that Speaker Johnson called for a collective House investigation to bolster this committee's effort that started in November.
Jun 11, 2024
Reauthorizing AGOA will ensure that American taxpayers get a positive return on their investment.
Apr 10, 2024
I think that we are in a much stronger place today because of the priorities of productivity in 2017.
Other voices in this conversation
